Function Oncology
San Diego, United States · Founded 2023 · $28.0M raised
- Headquarters
- San Diego, California
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- functiononcology.com
- Total Funding
- $28.0M
- Last Round
- $28.0M Series AApr 2023
- Rounds
- 1
About
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer at the individual patient level. Its platform performs CRISPR-based gene modulation directly on patient clinical samples to identify which drug targets are active in a specific tumor, enabling oncologists to select more effective, tailored treatment regimens. The company aims to move cancer treatment beyond population-average therapies toward truly individualized precision oncology.
Summary
Function Oncology is a Biotech company based in San Diego, United States, founded in 2023. It has raised $28.0M in total across 1 round, most recently a $28.0M Series A round in Apr 2023. Investors include Andreessen Horowitz, Section 32 and Casdin Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2023
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...


